StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
Qiagen N.V.
43.95
+1.16%
 

QGEN

 

Qiagen N.V.

$ 43.95

 
+$0.50 | +1.16%
 
 
Open
$ 43.62
 
 
MKT CAP
$ 9.73B
 
High
$ 44.04
 
 
VOL
$ 489.03K
 
Low
$ 43.47
 
 
AVG VOL
$ 1.21M
 
 
 

QGEN Stock Analysis

  Login to display Qiagen N.V. (QGEN) recommendation from the last 90 days from financial news and social media.
 
 

QGEN Total Score

 
 

Strengths

QGEN Rewards

 Earnings are forecast to grow

QGEN Rewards

 Upgraded on attractively valued

 
 

Chart

 
 

44.84

41.44

37.53

45.8

 
 
1month
3month
6month
1year
 
Total Return
QGEN
vs.
S&P500
 

 
1-week Return
+1.06%
 
+1.04%
 
 
5-week Return
-0.34%
 
+4.91%
 
 
10-week Return
+2.28%
 
+7.60%
 
 
 

QGEN Risk Level

This Indicator assigning QGEN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
QGEN Risk Level
LOW
HIGH

Risk Volatility

 

QGEN has Low Risk Level

Click here to check what is your level of risk

 

QGEN Analysts Opinion

QGEN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 

QGEN Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

5.00
 

QGEN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

NA
 

QGEN Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

3.85
 
 

Future

×
 

Future

2.50
 

QGEN Future Sentiment

 Earnings are forecast to grow

 
 

QGEN Analysts Opinion

QGEN Analysts opinion is positive and also has improved from the past 3 months

 

QGEN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
72%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
NA
50%
 
On Track
On Track
On Track
 

QGEN Street Opinion 

QGEN Street view is bullish but have mixed views on the near-term outlook

 

QGEN Performance Sentiment

Sentiments overview associated with QGEN events and the stock performance.
 
72%
17%
Positive
Negative
13 out of 18
events present
3 out of 18
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

QGEN Earnings

The TTM reflects 12-month period, providing review of QGEN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
1,954
2,142
2,252
-6.85%
 
 
Cost of Revenue
719
757
801
-5.26%
 
 
Gross Profit
1,235
1,385
1,451
-7.74%
 
 
Operating Exp
799
808
793
+0.38%
 
 
Operating Inc
436
576
658
-18.60%
 
 
Net Interest Inc
20
-26
-45
-
 
 
Interest Exp
56
58
54
+1.84%
 
 
Interest Inc
76
33
10
+175.68%
 
 
Other Income
-40
-38
13
 
 
EPS
1.46
2.53
2.26
-19.62%
 
 
Next Earnings Date: May 01, 2024
 
 
Highlights
Last Modify
Price
% Change

 
New Product
Today
43.95
+1.16%
 
New Product
This Week
43.49
-0.16%
 
Agreements
3 Weeks Ago
44.12
+1.40%
 
Weak Earnings
3 Weeks Ago
43.52
-2.81%
 
New Product
2 Month Ago
43.66
+0.28%
 
 
 
joker
 
 
 
StocksRunner

Explore our QGEN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our QGEN Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

QGEN Rewards

 Earnings are forecast to grow

QGEN Rewards

 Upgraded on attractively valued

 
 
 

QGEN Risk Level

 
 
 

The Indicator assigning QGEN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
QGEN Risk Level
LOW
HIGH

Risk Volatility

 

QGEN has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

QGEN

 

Qiagen N.V.

$ 43.95

 
+$0.50 | +1.16%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 43.62
 
 
MKT CAP
$ 9.73B
 
High
$ 44.04
 
 
VOL
$ 489.03K
 
Low
$ 43.47
 
 
AVG VOL
$ 1.21M
 
 
 

QGEN Analysis

  Sign in to view Qiagen N.V. (QGEN) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

44.84

41.44

37.53

45.8

 
 
1month
3month
6month
1year
 
Total Return
QGEN
vs.
S&P500
 

 
1-week Return
+1.06%
 
+1.04%
 
 
5-week Return
-0.34%
 
+4.91%
 
 
10-week Return
+2.28%
 
+7.60%
 
 
 

QGEN Analysts Opinion

QGEN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 

QGEN Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

5.00
 

QGEN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

NA
 

QGEN Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

3.85
 
 

Future

×
 

Future

2.50
 

QGEN Future Sentiment

 Earnings are forecast to grow

 
 

QGEN Analysts Opinion

QGEN Analysts opinion is positive and also has improved from the past 3 months

 

QGEN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
72%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
NA
50%
 
On Track
On Track
On Track
 

QGEN Street Opinion 

QGEN Street view is bullish but have mixed views on the near-term outlook

 
QGEN Performance Sentiment
Sentiments overview associated with QGEN events and the stock performance.
 
72%
17%
Positive
Negative
13 out of 18
events present
3 out of 18
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

QGEN Earnings

The TTM data reflects the most recent 12-month period, providing overview of QGEN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
1,954
2,142
2,252
-6.85%
 
 
Cost of Revenue
719
757
801
-5.26%
 
 
Gross Profit
1,235
1,385
1,451
-7.74%
 
 
Operating Exp
799
808
793
+0.38%
 
 
Operating Inc
436
576
658
-18.60%
 
 
Net Interest Inc
20
-26
-45
-
 
 
Interest Exp
56
58
54
+1.84%
 
 
Interest Inc
76
33
10
+175.68%
 
 
Other Income
-40
-38
13
 
 
EPS
1.46
2.53
2.26
-19.62%
 
 
Next Earnings Date: May 01, 2024
 
Highlights
Last Modify
Price
% Change

 
New Product
Today
43.95
+1.16%
 
New Product
This Week
43.49
-0.16%
 
Agreements
3 Weeks Ago
44.12
+1.40%
 
Weak Earnings
3 Weeks Ago
43.52
-2.81%
 
New Product
2 Month Ago
43.66
+0.28%
 
 
QGEN Latest News Feed

QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base. QIAGEN N.V.QGEN recently launched QIAGEN Biomedical KB-AI a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biotech industries. This new offering is designed for data scientists and bi

Today

Activity

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery. QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships including gene disease and drug causal relationships to aid in data-driven drug disco

Tue Feb 27, 2024

Activity

Qiagen upgraded at Morgan Stanley on valuation disconnect.

Fri Feb 16, 2024

Rating

volta labs partners with oem by qiagen to unlock potential of ngs sample prep. <

Thu Feb 8, 2024

Activity

qiagen (qgen) q4 earnings miss operating margin expands. qiagen n.v.&rsquo.s qgen fourth-quarter 2023 adjusted earnings per share (eps) were 55 cents (same at a constant exchange rate or cer) u

Wed Feb 7, 2024

Earnings

qiagen non-gaap eps of $0.55 in-line revenue of $503m misses by $2.09m.

Tue Feb 6, 2024

Earnings

earnings preview: qiagen. ) is set to give its latest quarterly earnings report on tuesday 2024-02-06. here'.s what investors need to know before the announcement. analysts estimate that qiagen will report an qiagen s will hope to hear the company

Mon Feb 5, 2024

Activity

qiagen (qgen) forges alliance to advance microbiome sciences. qiagen n.v.qgen recently announced a collaboration with penn state university united states to create a shared research and educati

Wed Jan 31, 2024

Activity

qiagen announces details of synthetic share repurchase plan of up to $300m.

Thu Jan 18, 2024

Activity

qiagen quickly ticks higher amid takeover speculation.

Tue Jan 16, 2024

Activity

qiagen (qgen) wins fda clearance for neumodx ct/ng assay. qiagen n.v.qgen recently received fda clearance for the neumodx ct/ng assay 2.0 growing its test menu for its integrated pcr-based clin

Fri Jan 12, 2024

Activity

qiagen (qgen) gains from new alliances amid fx headwind. qiagen&rsquo.s qgen business is expected to get a boost from its expanded test menu and growth-driving strategic collaborations. however

Tue Jan 9, 2024

Potential
Potential

qiagen to return around $300 mln to shareholders. (rttnews) - qiagen n.v. (qgen) said that it is planning to return $300 million or a maximum of 273 million euros to shareholders through a synthetic share repurchase that combines a direct capita

Mon Jan 8, 2024

Activity
Activity

qiagen plans to return about $300 mln to shareholders through synthetic share repurchase. (rttnews) - qiagen nv (qgen) said that it plans to return up to about $300 million or maximum 273 million euros to shareholders through a synthetic share r

Mon Jan 8, 2024

Activity
Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 18 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 16:31 Wall St. time
 
 

QGEN Total Score

 
 
 
 
 
 
 
StocksRunner

Discover QGEN Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of QGEN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our QGEN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

QGEN Stock trends

QGEN Stock performance

QGEN Stock analysis

QGEN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker